Substituted aryl piperidinylalkynyladenosines as A2AR agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8222228
APP PUB NO 20110091385A1
SERIAL NO

12981308

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A2A agonists of formula (I) is provided, wherein R1, R2, R4, R5, X, Y, Z, n, p, and q are as described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ADENOSINE THERAPEUTICS, LLC;FOREST LABORATORIES HOLDINGS LIMITED;TROVIS PHARMACEUTICALS, LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Rieger, Jayson M Charlottesville, US 49 775
Thompson, Robert D Charlottsville, US 69 1155

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 17, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00